Phase Forward CEO Bob Weiler Presides Over NASDAQ Stock Market Opening Bell, Commemorates Company`s Five Year Listing Anniversary

WALTHAM, Mass.--(Business Wire)--
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions
for clinical trials and drug safety, visited the NASDAQ MarketSite in New York
City`s Times Square earlier today to preside over the Opening Bell and celebrate
its five year anniversary of listing on The NASDAQ Stock Market.

For an archived webcast of the NASDAQ Opening Bell and high resolution
photographs of the Market Open, please go to
http://www.nasdaq.com/reference/marketsite_events.stm and click on Phase
Forward/Market Open.

Members of the media interested in speaking with Phase Forward should contact
Meghan Locke at 781-672-3147 or mlocke@chenpr.com.

About Phase Forward

Phase Forward is a leading provider of integrated data management solutions for
clinical trials and drug safety. Phase Forward`s products and services have been
utilized in over 10,000 clinical trials involving more than 1,000,000 clinical
trial study participants at over 290 organizations and regulatory agencies
worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer
Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline,
Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk,
PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis,
Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and
Healthcare Products Regulatory Agency. Additional information about Phase
Forward is available at www.phaseforward.com.

Phase Forward
Elaine Maynard, 781-902-4371
elaine.maynard@phaseforward.com
or
CHEN PR, Inc.
Meghan Locke, 781-672-3147
mlocke@chenpr.com

Copyright Business Wire 2009